Your browser doesn't support javascript.
loading
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
Kindler, Hedy L; Hammel, Pascal; Reni, Michele; Van Cutsem, Eric; Macarulla, Teresa; Hall, Michael J; Park, Joon Oh; Hochhauser, Daniel; Arnold, Dirk; Oh, Do-Youn; Reinacher-Schick, Anke; Tortora, Giampaolo; Algül, Hana; O'Reilly, Eileen M; Bordia, Sonal; McGuinness, David; Cui, Karen; Locker, Gershon Y; Golan, Talia.
Afiliação
  • Kindler HL; The University of Chicago, Chicago, IL.
  • Hammel P; Paul Brousse Hospital (AP-HP), University Paris-Saclay, Villejuif, France.
  • Reni M; IRCCS Ospedale, San Raffaele Scientific Institute, Vita e Salute University, Milan, Italy.
  • Van Cutsem E; University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium.
  • Macarulla T; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Hall MJ; Fox Chase Cancer Center, Philadelphia, PA.
  • Park JO; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Hochhauser D; University College London Cancer Institute, London, United Kingdom.
  • Arnold D; Asklepios Tumorzentrum Hamburg AK Altona, Hamburg, Germany.
  • Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Reinacher-Schick A; St Josef-Hospital, Ruhr University Bochum, Bochum, Germany.
  • Tortora G; Fondazione Policlinico A Gemelli IRCCS and Università Cattolica del Sacro Cuore, Rome, Italy.
  • Algül H; Klinikum rechts der Isar, Comprehensive Cancer Center Munich TUM, Technische Universität München, Munich, Germany.
  • O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Bordia S; Merck & Co Inc, Kenilworth, NJ.
  • McGuinness D; AstraZeneca, Cambridge, United Kingdom.
  • Cui K; AstraZeneca, Gaithersburg, MD.
  • Locker GY; AstraZeneca, Gaithersburg, MD.
  • Golan T; The Oncology Institute, Sheba Medical Center at Tel-Hashomer, Tel Aviv University, Tel Aviv, Israel.
J Clin Oncol ; 40(34): 3929-3939, 2022 12 01.
Article em En | MEDLINE | ID: mdl-35834777
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_endocrine_disorders / 6_ovary_cancer / 6_pancreatic_cancer Assunto principal: Neoplasias Ovarianas / Neoplasias Pancreáticas / Adenocarcinoma Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_endocrine_disorders / 6_ovary_cancer / 6_pancreatic_cancer Assunto principal: Neoplasias Ovarianas / Neoplasias Pancreáticas / Adenocarcinoma Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel